α-Substituted hydroxamic acids as novel bacterial deformylase inhibitor-based antibacterial agents
…, S Lopez, G Neckermann, C Wu, C Hackbarth…
Index: Jain; Sundram; Lopez; Neckermann; Wu; Hackbarth; Chen; Wang; Ryder; Weidmann; Patel; Trias; White; Yuan Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 23 p. 4223 - 4228
Full Text: HTML
Citation Number: 45
Abstract
We report the synthesis and biological activity of analogues of VRC3375 (N-hydroxy-3-R- butyl-3-[(2-S-(tert-butoxycarbonyl)-pyrrolidin-1-ylcarbonyl] propionamide), an orally active peptide deformylase inhibitor. This study explores the structure–activity relationship of various chelator groups, alpha substituents, P2′ and P3′ substituents in order to achieve optimal antibacterial activity with minimal toxicity liability.
Related Articles:
[Rodriguez-Llansola, Francisco; Miravet, Juan F.; Escuder, Beatriu Chemistry - A European Journal, 2010 , vol. 16, # 28 p. 8480 - 8486]
Inhibitors of pancreatic and leukocyte elastase
[Kasafirek, Evzen; Fric, Premysl; Slaby, Jan; Kocna, Petr Collection of Czechoslovak Chemical Communications, 1987 , vol. 52, # 12 p. 3034 - 3041]
Inhibitors of pancreatic and leukocyte elastase
[Kasafirek, Evzen; Fric, Premysl; Slaby, Jan; Kocna, Petr Collection of Czechoslovak Chemical Communications, 1987 , vol. 52, # 12 p. 3034 - 3041]
[Nilsson, Mikael; Haemaelaeinen, Markku; Ivarsson, Maria; Gottfries, Johan; Xue, Yafeng; Hansson, Sebastian; Isaksson, Roland; Fex, Tomas Journal of Medicinal Chemistry, 2009 , vol. 52, # 9 p. 2708 - 2715]